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            Concern about the impact of oral contraceptive (OC) use on women’s sexual 
functioning, particularly lowered sexual desire (or libido), has been expressed for almost as 
long as OCs have been available. Despite numerous studies over several decades, however, 
we still do not know the underlying mechanism for negative effects nor can we predict which 
women will suffer from them (Sanders, Graham, Bass, & Bancroft, 2001). Comment: Has 
anyone ever calculated effect sizes for negative effects, etc? 
The research has consistently produced mixed evidence, of two kinds. First, there is 
mixed evidence across studies: some report negative associations between desire and OC use, 
others find no effect, and still others report positive effects (for recent reviews, see Burrows, 
Basha, & Goldstein, 2012; Davis & Castano, 2004; Pastor, Holla, & Chmel, 2013; Schaffir, 
2006). Second, within their respective samples, studies also consistently report considerable 
individual variation in women’s experience: relatively large proportions of women 
experience a marked increase or decrease in desire, with others unaffected (Burrows et al., 
2012; Davis & Castano, 2004; Pastor et al., 2013; Schaffir, 2006). For example, in a 
prospective study, 17% had a higher frequency of sexual thoughts and 39% had a lower 
frequency, following initiation of OC use (Sanders et al., 2001). The picture is further 
obscured by wide variation between studies in both methodologies and OC formulations 
under test, but researchers typically conclude, on the basis of these mixed effects, that the 
influence of OC use on sexual desire is complex and likely due to multiple psychosocial 
influences (Burrows et al., 2012; Davis & Castano, 2004; Pastor et al., 2013; Schaffir, 2006). 
Indeed, the most recent review concluded that “we cannot define a single indicator reliably 
and clearly characterizing a cause-effect relationship. This is mainly due to the simultaneous 
and intertwined effects of a variety of complex biological, psychological, social, and 
multidimensional factors” (Pastor et al., 2013).  
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While this may be an accurate reflection of the current empirical state of affairs, it is 
clearly unsatisfactory both to women concerned about possible consequences for their 
relationships and to healthcare providers who are unclear about what advice to give. 
Perceived changes in libido and arousal are important contributors to OC switching and 
discontinuation (Sanders et al., 2001). Understanding the mechanism underpinning these 
mixed effects is therefore of significant public health concern and this is a matter of global 
importance. According to the UN report on World Contraceptive Use 2011, 9% of partnered 
women of reproductive age worldwide report using OC as their main contraceptive method, 
rising to 18% in some regions. In the United States, 82% of sexually experienced women, 
aged 18-44 years, had used OC at some stage of their lives (Mosher & Jones, 2010).  
  Against this background, new perspectives that might help to clarify the issue should 
be seized upon and scrutinized carefully. The possibilities that modulatory effects on mood or 
reduced circulating testosterone levels (e.g., through up-regulation of sex hormone binding 
globulin production) might be responsible for OC-associated change in sexual desire, for 
example, have been rigorously examined although neither adequately explains the data, at 
least to date (Pastor et al., 2013; Schaffir, 2006). But another promising perspective, from the 
interface between psychology and evolutionary biology, has so far been ignored or 
overlooked (at least judging by its absence in any recent review on the subject) (Burrows et 
al., 2012; Davis & Castano, 2004; Pastor et al., 2013; Schaffir, 2006). Briefly, this literature 
demonstrates that women’s partner preferences are influenced by OC use, meaning that 
attraction towards an existing partner changes over time if a woman initiates or discontinues 
OC use. This literature raises two key contextual issues. First, it is important to draw a clear 
distinction between general desire and that focused on partners; however, this distinction is 
absent in almost all previous clinical research. Second, rather than examining links between 
desire and current OC use, as previous researchers have done, studies also need to take into 
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account a woman’s previous use (i.e., during partner choice) and whether or not it matches 
her current OC use.  
In order to highlight this new perspective to clinical researchers interested in sexual 
and emotional side-effects of hormonal contraception, we therefore introduce the theoretical 
background to this body of research, summarize its key findings, describe some novel 
testable predictions, and discuss how this perspective might be incorporated in future 
research. 
Change in Partner Preference across the Menstrual Cycle 
At first glance, choice of a partner can appear to be a fundamentally idiosyncratic 
process. However, evolutionary biologists argue that at least part of the complexity in partner 
choice (in animals and humans alike) is explained by selection pressures across evolutionary 
history that shape inherent preferences for opposite-sex individuals carrying traits that reflect 
high mate quality (Andersson, 1994). Preference for any trait that confers benefits through 
improved survival, health or reproductive success of offspring will spread through a 
population.  
In mammals, female preferences among males vary with estrus (Williams & 
Lenington, 1993). There is now also considerable evidence from psychological studies that 
women’s preferences for varied male traits change across the menstrual cycle. These shifts are 
characterized by an increased periovulatory preference for traits that signal high partner 
quality, such as facial masculinity (Penton-Voak et al., 1999). Stronger preferences for such 
traits when conception probability is high suggest an evolved mechanism by which females 
maximize quality of mating partners and, hence, of potential offspring (Gangestad & 
Thornhill, 2008; Jones et al., 2008; Penton-Voak et al., 1999). Cyclical shifts may be due to 
differential activational effects in the brain when processing mate choice relevant stimuli 
around ovulation (Roberts, Newell, Simoes-Franklin, & Garavan, 2008), which are mediated 
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by hormonal levels. For example, shifting preferences for masculine male faces or vocal traits 
are mediated by changing levels of estradiol or its metabolites (Feinberg et al., 2006; Roney & 
Simmons, 2008). OCs exploit these natural fluctuations, through negative feedback effects on 
the hypothalamus and anterior pituitary gland, suppressing gonadotropin release and 
inhibiting ovulation. Furthermore, they also appear to nullify or reduce the preference shifts 
evident in normally cycling women (Jones et al., 2008; Penton-Voak et al., 1999).  
If OC use influences these preference shifts, we should see differences in mate 
preference between OC users and non-users. Indeed, a growing number of studies show that 
OC users make different mate choices, on average, than non-users, including in preferences 
for facial and vocal masculinity and for perceived health in faces (Alvergne & Lummaa, 
2010; Jones et al., 2008; Penton-Voak et al., 1999). Furthermore, in a recent study, initiation 
of OC use reduced women’s preference for male facial masculinity (Little, Burriss, Petrie, 
Jones, & Roberts, 2013). Consistent with this, the actual partners of women who were using 
OC when couples met were also found to have less masculine faces, both in terms of 
measurements of facial shape and perceptual judgments by independent raters, compared with 
partners of women who did not use OC when couples met (Little et al., 2013). 
MHC-Correlated Partner Preference 
Another well-documented factor involved in partner selection is preference for 
genetically dissimilar partners (Roberts & Gosling, 2003; Roberts & Little, 2008). 
Vertebrates achieve this using odor, which reveals dissimilarity at key genes in the major 
histocompatibility complex (MHC). Odor-mediated MHC-disassortative mating promotes 
offspring heterozygosity and is evolutionarily beneficial because of heterozygote advantage 
in resistance to infection. MHC-disassortative mating occurs across fish, reptiles, birds, and 
mammals (Milinski, 2006; Penn, 2002; Roberts, 2009; Setchell & Huchard, 2010). In some 
socially monogamous birds and mammals (including primates), females not only choose to 
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pair with MHC-dissimilar mates but are also more likely to engage in extra-pair copulations 
(evidenced by mixed paternity clutches) if their mate is relatively MHC-similar (Freeman-
Gallant, Wheelwright, Meiklejohn, & Sollecito, 2006; Schwensow, Fietz, Dausmann, & 
Sommer, 2008); in so doing, they gain further genetic diversity in their offspring, with 
associated benefits in offspring health and survival (Foerster, Delhey, Johnsen, Lifjeld, & 
Kempenaers, 2003; Petrie & Kempenaers, 1998).  
Humans, too, can discriminate MHC similarity through odor: in laboratory tests, 
women in the follicular phase tend to rate axillary odor of MHC-dissimilar men as more sexy 
and attractive than those of MHC-similar men (Havlicek & Roberts, 2009; Wedekind & Füri, 
1997; Wedekind, Seebeck, Bettens, & Paepke, 1995). Differences in preference for MHC 
dissimilarity also occur between OC users and non-users, with users showing weaker 
preference (Havlicek & Roberts, 2009; Wedekind & Füri, 1997; Wedekind et al., 1995). It 
seems unlikely that differences in psychosocial factors could explain relative odor 
preferences, so the difference appears to be hormonally mediated. Indeed, a longitudinal 
study showed that initiating OC use caused a change in odor-mediated MHC preference in 
women, compared to a control group of non-users tested across the same (3-month) interval 
(Roberts, Gosling, Carter, & Petrie, 2008). If olfaction plays any part in attractiveness 
assessments during courtship, as it seems to (Havlicek et al., 2008), this body of work then 
suggests that OC use will increase the likelihood of women selecting more MHC-similar 
partners than they otherwise would (Roberts et al., 2008).  
Defining the Object of Desire 
This literature thus demonstrates potential for OC use to alter women’s partner 
preference for a range of male traits, at a deep-seated and subconscious level. This could have 
important consequences on women’s sexual relationships, because it alters women’s 
attraction to their partner and, potentially, to other men. For example, in a study of U.S. 
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women in established relationships, those partnered with men who shared a relatively high 
number of MHC alleles expressed lower sexual responsivity and satisfaction with their 
partner compared with women whose partner was relatively MHC-dissimilar, especially near 
ovulation (Garver-Apgar, Gangestad, Thornhill, Miller, & Olp, 2006). Furthermore, in the 
same women, within-couple MHC similarity was also associated with higher frequency of 
women’s sexual thoughts about, and actually engaging in sexual activity with, other men. 
This raises a fundamental consideration for studies of the relationship between OC 
use and female sexual desire: a critical distinction must be made between a woman’s general 
desire and her specific desire for her partner. Previous studies have almost ubiquitously failed 
to make this distinction. These studies typically employ one of a range of standard 
questionnaires to measure desire, but examination of these scales shows that they lack 
sufficient specificity in their respective lists of items. Table 1 shows the higher-order facets 
of female sexuality and the target (general or partner-focused) specified in the questionnaire 
rubric, for six of the most commonly used questionnaires when addressing this question. 
While each contains items that quantify general sexual desire, not one contains an item 
specifically about desire for (nor indeed about arousal, lubrication or orgasm during sex with) 
the woman’s main sexual partner. Furthermore, even though several questionnaires contain 
items relating to partner-focused sexual satisfaction, which is likely correlated with desire, 
these items are often subsumed within global sexuality scores or in desire subscales which 
also incorporate general sexual desire (e.g., Panzer et al., 2006; Wallwiener et al., 2010).  
Failing to make this distinction potentially conflates two very different forms of 
sexual desire and experience. Discounting research emerging from the literature on OC 
influence on partner choice (Roberts et al., 2012), a study by Bancroft, Sherwin, Alexander, 
Davidson, and Walker (1991), to our knowledge, is the only one to have yet made this 
distinction, which makes it of particular interest. Their main goal was to examine the 
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influence of testosterone on sexual attitude and behavior, and they included groups of OC 
users and non-users because of the known effects of OC use on lowered testosterone. 
Interestingly, they did not find the predicted relationships in non-users, but, in OC users, 
testosterone predicted lower satisfaction with the woman’s relationship at the same time as a 
more permissive attitude to extramarital involvement. This seems strongly reminiscent of the 
effects of MHC allele sharing on women’s sexual behavior. Bancroft et al. concluded that this 
effect probably arose through psychosocial factors more evident in non-users (e.g., cyclical 
mood change) obscuring the activational effects of testosterone on sexuality. This is certainly 
plausible, but an alternative view is that it arises not because of characteristics of non-users 
masking these activational effects, but rather through a change in partner preference in the 
OC users, which then brings the predicted activational effects to the fore. 
The Congruency Hypothesis 
Studies demonstrating the influence of OC on partner choice also lead to a novel but 
simple model for understanding interactions between timing of previous and current oral 
contraceptive use, relationship initiation, and partner-focused desire. This is that congruence 
between current OC use and previous use (specifically during relationship formation) should 
more accurately predict a woman’s sexual desire for, and satisfaction with, her partner than 
current OC use in isolation. This is because if a woman’s OC use is congruent (i.e., current 
OC users who were OC users when they met their partner, current non-users who were non-
users when they met their partner), her current preference will more closely match the 
preference that shaped her partner choice in the first place; the corollary is relatively higher 
desire for that partner than a woman whose use is incongruent (Fig. 1).  
This idea potentially explains some previously reported effects. In prospective studies, 
participants are often young women in committed relationships who have not used hormonal 
contraception for at least a significant period. It seems reasonable to suppose that many 
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women in such samples were non-users when their relationship began, and the commonly 
reported experience of decreased sexual desire after initiating OC use is then consistent with 
this hypothesis. A significant difference in effect between married and age-matched single 
women, with the former being more likely to experience decreased desire when prescribed 
OC’s (Gambrell, Bernard, Sanders, Vanderburg, & Buxton, 1976), is also consistent with this 
idea.  
 The hypothesis generates testable predictions. One is that women who meet their 
partner while using OC will tend to experience decreased desire when they subsequently 
cease use, as their partner preferences realign to their baseline state. A recent study tested this 
prediction in a survey of >2500 women. As predicted, among current non-users, those who 
had used OC when they met their partner reported lower attraction to, and lower sexual 
satisfaction with their partners, compared with those who had been non-users (Roberts et al., 
2012). A second, but so far untested, prediction is that women who were non-users when they 
met their partner and who subsequently initiate OC use will tend to experience similar 
negative effects on sexual desire, arousal, and satisfaction.  
Thus, the congruency hypothesis suggests that decreased desire could be experienced 
both by ceasing and initiating OC, critically depending on the individual’s OC use when the 
relationship began (Fig. 1). This could help to explain the consistently high variation in 
women’s experience that is characteristic of previous studies.  
Future Directions 
There is growing recognition of the importance of evolutionary insights in 
complementing other approaches to medicine (Stearns, Nesse, Govindaraju, & Ellison, 2010). 
To the longstanding debate about OC use and adverse sexual side-effects, the evolutionary 
perspective on partner choice offers two new, potentially important contributions. Both serve 
to contextualize aspects of the women’s experience, and both have the potential to explain 
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previous patterns of results, probably in combination with each other. This is not to 
definitively conclude that other mechanisms are unimportant. For example, altered desire due 
to suppression of circulating testosterone during OC use may act in conjunction with these 
effects, or be obscured by them. However, weighing effects of testosterone suppression 
against other factors, Pastor et al. (2013) concluded in their recent review that psychological, 
social and personal characteristics exert greater influence. On this basis, and in view of the 
evolutionary evidence, we suggest that OC effects on partner choice now deserve rigorous 
consideration alongside other approaches.  
The following prospective study would provide a definitive test of these ideas, 
stemming from the second prediction generated by the congruency hypothesis. Researchers 
could recruit an appropriate sample of women in committed relationships, half of whom were 
on (and half off) OC when they met their partner, with none being current users. The study 
would measure change in desire across the transition to OC use. A control group of non-
users, half of whom used OC when they met their partner, receive a placebo. Because 
psychosocial effects on relationship-relevant variables are sensitive to estradiol dose within 
OCs (Cobey et al., 2012; Cobey, Pollet, Roberts, & Buunk, 2011; Welling, Puts, Roberts, 
Little, & Burriss, 2012), the tested OC formulation would ideally be similar to the women’s 
previous brand. The hypothesis would predict that (1) there will be greater absolute (i.e., 
unsigned) change in desire in the treatment group, and that OC initiation leads to (2) 
increased desire among women who were using OC when they met their partner and (3) 
decreased desire among women who were non-users when they met their partner. 
 However, in any future work (not just the study outlined above), the evidence also 
highlights the need for greater attention to certain aspects of study design. First, more care is 
needed in interpreting how other facets of female sexual experience might relate to desire 
(Basson, 2008; Levine, 2003). While arousal, lubrication, frequency of sex/orgasm, and 
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satisfaction may be motivationally interlinked and underpinned by the degree of current 
attraction to the woman’s partner, autosexual behavior may be motivationally distinct and 
perhaps inversely related with partner attraction. However, currently, this is included in two 
of the commonly used measures (Table 1) and in calculation of global sexuality scores in 
some studies (e.g. Caruso et al., 2005). 
 Second, measures of desire need to be fit for purpose. This is a more important point 
than engaging in a debate about which measure to use or about wording of individual items. 
Our contention is that none of the commonly used questionnaires adequately capture the 
subtle, but potentially critical, changes in the target of women’s desire exposed by the 
evolutionary perspective. Future studies should thus use a measure that explicitly identifies 
the target of different facets of sexual behavior, dissecting the expression of desire and 
experience to distinguish between a woman’s main sexual partner and other partners (real or 
imagined). We are aware that women’s attitudes towards extra-pair sex is variable and that 
this variability may introduce further complexity in measuring effects (Levine, 2003); 
however, the available evidence suggests this can be informative (Garver-Apgar et al., 2006), 
and well-recognized measures exist to control for this variability (e.g., the revised 
Sociosexual Orientation Inventory) (Penke & Asendorpf, 2008). 
Finally, the literature on OC use and partner preference, along with parallel effects of 
OC’s on factors such as relationship jealousy (Cobey et al., 2012), emphasize the need for 
studies to record and control for relationship status. It is perhaps remarkable that several 
studies fail to do this (e.g. Fortenberry & Hensel, 2011; Panzer et al., 2006). Even in those 
that do, including many who specifically recruit partnered women, few record changes in 
relationship status across the study. However, women whose status changes during the study 




It is now almost two decades since the idea that partner preference might be influenced 
by OC use was first proposed (Wedekind et al., 1995), but this rapidly growing body of 
evolutionarily informed research has been overlooked by contraception practitioners in 
general (Cobey & Buunk, 2012), and by those working on psychosexual effects of hormonal 
contraception in particular (Burrows et al., 2012; Davis & Castano, 2004; Pastor et al., 2013; 
Schaffir, 2006). It may be that something as apparently esoteric as individual preferences for 
partners is simply viewed with skepticism, or clinical researchers may be unaware of it. 
Either way, we hope this Letter will stimulate researchers to incorporate these contextual 
perspectives when investigating these effects in future, and that this may ultimately lead to 
more informed discussion between practitioners and users about their contraceptive choices, 
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Table 1   Facets of sexual experience in questionnaires exploring associations between 








FSFI MFSQ SDI SEQ PEQ SPEQ 
General       
Desire + + + + + + 
Arousal + + - - + + 
Lubrication + + - + + - 
Orgasm + + - - + + 
Satisfaction
c
 + + - + + + 
Pain + + - - - + 
Frequency - + - - + + 
Autosexual - - + - + - 
       
Partner-focused       
Desire - - - - - - 
Arousal - - - - - - 
Lubrication - - - - - - 
Orgasm - - - - - - 
Satisfaction
c
 + + - - + + 
Pain - - - - + - 
Frequency - - - - + - 
a
Facets are presented separately for questionnaire items dealing with general sexual 
functioning and those specifically targeted at sex with a woman’s main partner. 
b
Questionnaires: FSFI, Female Sexual Function Index (Rosen et al., 2000); MFSQ, McCoy 
Female Sexuality Questionnaire (McCoy, 2000); SDI, Sexual Desire Inventory (Spector, 
Carey, & Steinberg, 1996); SEQ, Side Effects Questionnaire (Sanders et al., 2001); PEQ, 
Personal Experiences Questionnaire (Dennerstein, 1997); SPEQ, Short Personal Experiences 
Questionnaire (Dennerstein, Lehert, & Dudley, 2001). 
c








Figure 1.  Congruency in current and previous OC use: effects on partner-specific 
desire. The figure shows how, according to the congruency hypothesis, congruency (light 
grey shading) or non-congruency (dark grey) in OC use between different critical periods 
predicts variation in partner-specific desire.  (a) In cross-sectional studies, OC use during 
sampling may be associated with both higher and lower levels of partner-focused desire 
dependent on previous use during relationship formation. (b) In prospective studies, an 
intervention (i.e. initiating or discontinuing OC use) may induce similar mixed effects. 
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